Cancer-related Cognitive Difficulties
7
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (7)
CanCOG®: Pilot Trial of Cognitive Rehabilitation for Cancer Survivors
Modafinil to Improve Fatiguability
Clinical Investigation of the Effects of Semiconductor Embedded Therapeutic Garments on Cancer-related Cognitive Impairment in Breast and Gynecological Cancer Patients
Use of a Virtual Reality Cognitive Stimulation Programme for Breast Cancer Patients Wishing to Restart or Maintain a Professional Activity
Improve Cancer-related Cognitive Impairment
An Online Cognitive Assessment in Cancer Patients
The Effects of Physical Activity and Low-Dose Ibuprofen on Cognitive Function in Cancer Patients